Clinical trial
Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to…
NCT00005094 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00005094 |
|---|---|
| Title | Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps |
| Official title | Prevention of Sporadic Colorectal Adenomas With Celecoxib |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colon Cancer, Rectal Cancer |
| Intervention type | Drug, Other |
| Interventions | celecoxib, placebo |
| Enrollment | 1,170 |
| Start date | Mar 1, 2000 |
| Primary completion | Apr 1, 2006 |
| First posted | Nov 5, 2003 |
| Last update posted | Apr 12, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: